Novavax (NVAX) Misses Q1 EPS by 1c
Tweet
Share
E-mail
Get Alerts NVAX Hot Sheet
Price: $10.30 +0.78%
Financial Fact:
Basic and diluted net loss per share: -0.24
Today's EPS Names:
VIVO, BIOX, PMCB, More
Financial Fact:
Basic and diluted net loss per share: -0.24
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) reported Q1 EPS of ($0.14), $0.01 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $9.7 million versus the consensus estimate of $9.33 million.
For earnings history and earnings-related data on Novavax (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- United Natural Foods (UNFI) Tops Q4 EPS by 8c ; Offers Guidance
- HSBC explains why risk assets continue to ignore every negative catalyst
- Labcorp acquires MLM Medical Labs to expand lab network
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
